PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20145140-7	2010	Inhibition of BCR/ABL by imatinib or nilotinib (AMN107) led to decreased expression of the Plk1 protein in CML cells, suggesting that BCR/ABL promotes Plk1 generation.	nilotinib	37-46	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	14-21	
20145140-7	2010	Inhibition of BCR/ABL by imatinib or nilotinib (AMN107) led to decreased expression of the Plk1 protein in CML cells, suggesting that BCR/ABL promotes Plk1 generation.	nilotinib	37-46	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	134-141